BioHealth Capital Region – Regional Life Sciences Roundup – November 16, 2026
The BioHealth Capital Region built infrastructure this week. The pattern ran across facility openings, education programs, research networks and leadership appointments. Each filled in a different part of the region’s research and education infrastructure.
ATCC opened its Centennial Biomanufacturing Center in Manassas, expanding U.S. production of authenticated biomaterials for biomedical research, product development and public health preparedness. The facility expands ATCC’s presence across both sides of the Potomac River. PQE Group and CAI entered a definitive agreement to form a global life sciences services market leader, pairing complementary expertise in data integrity and validation services supported by New York-based private equity firm JLL Partners.
The people’s side followed the same path. Everett Cunningham, a veteran diagnostics and commercial leader with more than 35 years of experience, was named Chief Executive Officer of GeneDx in Gaithersburg. He joins GeneDx from Quanterix Corporation, where he most recently served as President and Chief Executive Officer, and brings senior roles from Illumina, Exact Sciences, GE Healthcare, Quest Diagnostics and Pfizer. Dr. John H. Powers III was named director of NIH’s National Institute of Allergy and Infectious Diseases, where he will oversee basic and applied research to understand, treat and prevent infectious, immunologic and allergic diseases. Karen Snow, former Global Head of Listings at Nasdaq, joined BioTech Social Inc.’s Advisory Board, bringing more than 30 years of experience across investment banking, capital markets, corporate strategy, governance, sales, and company growth. OTraces selected Labcorp for prostate cancer biomarker testing in a Florida Department of Health-funded study of about 950 men with elevated PSA.
This week shows the region building capacity at every level, from student pathways to research infrastructure to clinical research networks. Each partnership sets up what comes next.
Financial
Tracking the capital moving through the BioHealth Capital Region: funding rounds, M&A activity, and investment trends shaping Maryland, DC, and Virginia’s life sciences companies.
Eight Montgomery County Companies Raise Almost $71 Million in Investments Last Month, Montgomery County Economic Development Corporation
Eight Montgomery County companies raised almost $71 million in investments last month, according to the Montgomery County Economic Development Corporation. The capital flowed into life sciences and technology firms across the county, led by companies including Regenxbio and Precigen. The investments reflect continued activity in one of the region’s densest biotech corridors. Read More >
A Race Against Blindness Commits a Second $1 Million Gift to Advance Gene-Agnostic Therapeutic Approaches
A Race Against Blindness committed a second $1 million gift to advance gene-agnostic therapeutic approaches for inherited retinal diseases. The commitment directs $700,000 to the Gund Vision Fund, to be matched by the Gordon and Llura Gund Foundation as part of the Fund’s ongoing fundraising campaign, and $300,000 to a Foundation Fighting Blindness research award advancing a regenerative, gene-agnostic therapy. Read More >
People
Who we’re buzzing about this week: the leadership moves, board appointments, and rising names shaping the region’s life sciences community.
BioTech Social Welcomes Former Nasdaq Global Head of Listings Karen Snow to Advisory Board
BioTech Social, parent company of BioTech Funding Portal, announced that Karen Snow, former Global Head of Listings at Nasdaq, has joined its Advisory Board. Snow brings more than 30 years of experience across investment banking, capital markets, corporate strategy, governance, and company growth. BioTech Social is building financial infrastructure around life science innovation, starting with its SEC-registered and FINRA-member Regulation Crowdfunding portal. Read More >
GeneDx Announces Leadership Transition
GeneDx named Everett Cunningham as Chief Executive Officer and board member, effective on or before December 15, 2026. Cunningham joins the Gaithersburg rare disease diagnostics company from Quanterix Corporation, where he served as President and CEO. Katherine Stueland will step down as CEO and remain with GeneDx in an advisory capacity through January 31, 2027. Read More >
Dr. John H. Powers III to serve as director of NIH’s National Institute of Allergy and Infectious Diseases
Dr. John H. Powers III will serve as director of NIH’s National Institute of Allergy and Infectious Diseases. NIAID conducts and supports basic and applied research to better understand, treat, and ultimately prevent infectious, immunologic, and allergic diseases. The appointment was announced by the National Institutes of Health. Read More >
Workforce
The hiring activity, team expansions, and talent trends driving growth across Maryland, DC, and Virginia’s life sciences and biotech employers.
UVA Engineering Meets Industry Demand With New Biotechnology Minor
The University of Virginia School of Engineering and Applied Science launched a new biotechnology minor to meet industry demand for interdisciplinary training. The program is designed to prepare engineering students for careers at the intersection of engineering, biology, and medicine. Read More >
Grow With Your Region, Not Just In It: ATCC’s Success Story
ATCC shared lessons from its century of growth at BioBuzz Community Connect on October 22, 2026, at Montgomery College’s Germantown campus. Ruth Cheng, President and CEO of the nonprofit biological standards organization, discussed how ATCC built operations across the BioHealth Capital Region by partnering with industry, government, and academia. She highlighted five principles, including choosing ecosystems over real estate, championing the future workforce through sustained university partnerships, and treating collaboration as infrastructure rather than a side activity. Read More >
Montgomery College Among Only Nine Community Colleges Nationwide Selected for New Science Honors Program
Montgomery College was selected as one of only nine community colleges nationwide for a new science honors program by the Howard Hughes Medical Institute. The program aims to strengthen science education pathways for community college students. The selection recognizes Montgomery College’s role in preparing students for careers in science, technology, engineering, and mathematics. Read More >
Who’s Hiring
| TOP EMPLOYER | ||||||
| ||||||
| View all jobs on BioBuzz |
Clinical + Commercial
The latest clinical trial progress, regulatory milestones, and commercial launches from companies advancing science from the lab to the market across the BioHealth Capital Region.
IGC Pharma Completes Dosing in Phase 2 CALMA Trial of IGC-AD1 for Agitation in Alzheimer’s Dementia – IGCPharma
IGC Pharma completed dosing in its Phase 2 CALMA trial of IGC-AD1 for agitation in Alzheimer’s dementia. The final participant in the 170-participant trial completed the six-week treatment phase, and all required visits and assessments are complete. The Potomac company anticipates topline results during the December 2026 or January 2027 timeframe. The trial randomized participants across clinical sites in the United States and Canada. Read More >
Klygefa (gefurulimab) approved in the US for the treatment of generalised myasthenia gravis (gMG) in adult patients
Klygefa (gefurulimab) received FDA approval for the treatment of generalised myasthenia gravis in adult patients. AstraZeneca announced the approval for the autoimmune disorder, which causes muscle weakness and fatigue. Klygefa is administered intravenously and targets a specific immune pathway involved in the disease. Read More >
NIH research team lays groundwork for new treatment of Niemann-Pick Type C in infants
An NIH research team laid the groundwork for a new treatment of Niemann-Pick Type C in infants, work spanning two decades that culminated in an approved drug for the rare and deadly neurological disease. The research was conducted at the National Institutes of Health and resulted in a therapy now available for use. Niemann-Pick Type C is a genetic disorder that disrupts the body’s ability to metabolize cholesterol and other lipids. Read More >
Ecosystem
The partnerships, programs, and policy moves building the BioHealth Capital Region’s life sciences infrastructure, and the organizations driving it forward.
OTraces Picks Labcorp for Prostate Cancer Biomarker Testing
OTraces, a Deerfield Beach, Florida diagnostics company, selected Labcorp to perform biomarker testing for a Florida Department of Health-funded prostate cancer study. Labcorp will run a panel of serum biomarkers on samples from approximately 950 men enrolled at Florida clinical sites. The 12-month study is supported by a $2 million grant under the Florida Cancer Innovation Fund to improve biopsy decision-making for men with elevated prostate-specific antigen levels. Read More >
PQE Group Enters a Definitive Agreement to form Global Life Sciences Services Market Leader with CAI
PQE Group, a Florence, Italy-based consulting firm with Maryland operations, entered a definitive agreement with CAI to form a global life sciences services provider, backed by New York private equity firm JLL Partners. The partnership will combine PQE’s expertise in data integrity, computer system validation, and quality compliance with CAI’s capabilities in commissioning, qualification, validation, and operational readiness. The combined organization will operate across North America, Europe, Latin America, and Asia-Pacific. Read More >
Inovalon To Acquire Intelligent Medication Management Company DrFirst
Inovalon announced its acquisition of DrFirst, the Rockville medication management software company. The combination will extend Inovalon’s product reach into clinical workflows, adding real-time prescription drug and prior authorization capabilities. The deal will put richer information and intelligent decision support directly into the workflows where healthcare decisions are made and bring patients additional resources to improve medication access and adherence. Read More >
ATCC Opens Centennial Biomanufacturing Center
ATCC opened its Centennial Biomanufacturing Center, expanding production capacity for authenticated biomaterials used in biomedical research, product development, and public health preparedness. The nonprofit biological standards organization received $99 million in federal funding to support the facility, which serves researchers and companies worldwide. ATCC operates across the BioHealth Capital Region, with sites in Virginia and Maryland and partnerships spanning industry, government, and academia. Read More >
Client News
News from the member companies we work with.
Ayatris Inc. Awarded TEDCO Equitech Growth Fund Grant for Human-Relevant Drug Discovery Infrastructure
Ayatris Inc. was awarded a TEDCO Equitech Growth Fund grant for human-relevant drug discovery infrastructure on November 18, 2026. Read More >
Other [Good] Reads
Editor’s picks from across the web: the stories, videos, and podcasts shaping the conversation in DMV biotech and life sciences this week.
University of Maryland team builds archive for first comprehensive atlas of basal ganglia
Researchers at the University of Maryland School of Medicine’s Institute for Genome Sciences developed the NeMO Archive, a research tool that houses data on more than 50 million brain cells and supports a multi-institution effort to create the first comprehensive atlas of basal ganglia cell types across four species. Read More >
AI facial analysis offers new sickle cell insights
Researchers at Children’s National in Washington, DC used AI facial analysis to identify subtle facial differences linked to sickle cell disease in 308 children and young adults. The team’s machine learning model found 14 facial features that differed between participants with sickle cell disease and matched controls. The study was published in PLOS Digital Health. Read More >
On the Calendar
A few of the upcoming events, conferences, and networking opportunities across the BioHealth Capital Region’s life sciences ecosystem that you don’t want to miss.
PIC MC Presents: The Tour (Group B)
Thursday, November 19 · 1 PM–3 PM · Hughes Network Systems, LLC, Germantown, Maryland
Hosted by PIC MC | Register Now >
Aseptic Processing Essentials Workshop (PDA 374)
Tuesday, December 1 · 1:30 PM–9 PM · Bethesda, MD
Hosted by Parenteral Drug Association | Register Now >
Advanced Topics in Gene Editing with CRISPR
Wednesday-Friday, December 2-4 · 9:00 AM–5:00 PM · Germantown, MD
Hosted by Bio-Trac | Register Now >
Did we miss something!? Drop us a line →
Stay connected to BioHealth Capital Region life sciences.